Calculators Vaccination calendar

Vaccination calendar · 🇬🇧 United Kingdom

National vaccination programme according to United Kingdom's official source. 20 entries shown.

Interactive engine only available in the ES version — for United Kingdom the corpus is shown without dynamic filters.

RSV (respiratory syncytial virus)

Target: age_from:75 · age_to:null · sex:any · conditions:[age_75_plus_routine · expanded_2026_04_01_to_age_80_plus_no_upper_limit · care_home_residents_any_age]

Single dose. 75-79 routine since Sept 2024. From 1 April 2026: expanded to ≥80 with NO upper age limit + all residents in care homes for older adults (regardless of age). Co-administration with COVID-19 spring 2026 campaign permitted.

RSV (maternal — infant protection)

Target: age_from:null · age_to:null · sex:female · conditions:[pregnancy_from_28_weeks]

Single dose from 28 weeks gestation in every pregnancy (protects infant via transplacental antibody).

Shingles (herpes zoster)

Target: age_from:65 · age_to:79 · sex:any · conditions:[aged_65_or_70_per_phased_rollout · eligible_until_80th_birthday]

2 doses Shingrix (0, then 2-6 months; up to 12 months). Phased age expansion (65 and 70 cohorts) toward routine 60-80 over time. Replaced Zostavax (live) — Shingrix non-live.

Shingles (herpes zoster)

Target: age_from:18 · age_to:null · sex:any · conditions:[severely_immunosuppressed]

Severely immunosuppressed adults 18+ eligible for Shingrix (non-live, safe in immunosuppression unlike old Zostavax).

Pneumococcal

Target: age_from:65 · age_to:null · sex:any · conditions:[aged_65_no_prior_PPV23]

Single dose PPV23 at 65 (one-off, not routinely repeated). Transition to PCV20 underway as PPV23 stock is exhausted.

Pneumococcal

Target: age_from:2 · age_to:null · sex:any · conditions:[asplenia_or_splenic_dysfunction · chronic_heart_lung_liver_kidney_disease · diabetes · immunosuppression · cochlear_implant · CSF_leak · complement_disorders]

At-risk groups: PPV23 (revaccination every 5 years only for asplenia/CKD/immunosuppressed). Occupational: welders + metal-fume exposure now an at-risk indication (JCVI).

Influenza (inactivated)

Target: age_from:65 · age_to:null · sex:any · conditions:[annual_from_september]

Annual inactivated influenza vaccine (aQIV adjuvanted or cell-based preferred 65+).

Influenza (inactivated)

Target: age_from:null · age_to:null · sex:any · conditions:[pregnancy · clinical_risk_group · carer · frontline_health_social_care_worker]

Annual flu vaccine for pregnant women (any stage), clinical risk groups, carers, and frontline health/social care workers (occupational — employer-provided).

COVID-19 (seasonal)

Target: age_from:null · age_to:null · sex:any · conditions:[per_JCVI_seasonal_cohort] · risk_modifiers:[75_plus · immunosuppressed · care_home_resident]

Seasonal boosters per JCVI advice each campaign (cohorts vary by season — typically 75+, immunosuppressed, older-adult care home residents). NOT universal.

Pertussis (whooping cough) in pregnancy

Target: age_from:null · age_to:null · sex:female · conditions:[pregnancy_from_16_weeks · ideally_before_32_weeks]

Single dose from 16 weeks gestation (ideally before 32 weeks) every pregnancy — infant protection. NOTE: pregnancy is the main UK adult pertussis indication (no routine non-pregnant adult Tdap).

Tetanus / diphtheria / polio (Td/IPV)

Target: age_from:14 · age_to:null · sex:any · conditions:[complete_5_dose_lifetime_course · tetanus_prone_wound · incomplete_history]

UK uses Td/IPV (Revaxis) for adult boosters — NOT US-style Tdap. 5 doses confer lifelong protection. Boosters for tetanus-prone wounds or incomplete history; teenage booster at 14 (school Year 9).

MMR (measles, mumps, rubella)

Target: age_from:null · age_to:null · sex:any · conditions:[no_evidence_of_2_doses_or_immunity]

2 doses (≥1 month apart) for any adult without documented 2 doses or immunity. Occupational priority: healthcare/laboratory + education staff. UK measles resurgence — active catch-up.

HPV (human papillomavirus)

Target: age_from:12 · age_to:25 · sex:any · conditions:[routine_school_year_8 · catch_up_to_25_if_missed]

SINGLE dose (UK moved from 2 doses to 1 dose, Sept 2023) for immunocompetent under 25. Routine school Year 8 (12-13); catch-up to 25th birthday if eligible and missed.

HPV (human papillomavirus)

Target: age_from:null · age_to:45 · sex:male · conditions:[MSM_up_to_45_via_sexual_health_GUM]

MSM up to 45 offered HPV via sexual health/GUM services (immunocompetent: doses per current guidance; immunocompromised/HIV: 3 doses).

Hepatitis B

Target: age_from:null · age_to:null · sex:any · conditions:[occupational_exposure_blood_body_fluids · HCW · lab_staff · renal_dialysis · PWID · MSM · household_sexual_contact_HBV]

Occupational HBV programme for HCW/lab/exposure-prone procedures: 3-dose (0,1,6) or accelerated; post-vaccination anti-HBs check (≥10 mIU/mL adequate). Employer-provided under COSHH.

Hepatitis A

Target: age_from:null · age_to:null · sex:any · conditions:[occupational_sewage_lab · travel_endemic · MSM · PWID · chronic_liver_disease · haemophilia]

At-risk: sewage workers, lab staff handling HAV, travellers to endemic areas, MSM, PWID, chronic liver disease.

Meningococcal ACWY

Target: age_from:null · age_to:25 · sex:any · conditions:[new_university_entrant_under_25 · asplenia · complement_deficiency · travel_hajj_or_meningitis_belt]

New university entrants <25 (freshers); asplenia/complement disorders; travel to meningitis belt/Hajj (Saudi visa requirement).

Meningococcal B

Target: age_from:null · age_to:null · sex:any · conditions:[asplenia_splenic_dysfunction · complement_deficiency · complement_inhibitor_eculizumab_ravulizumab · lab_workers_handling_meningococcus]

At-risk only in adults: asplenia, complement deficiency, complement-inhibitor therapy, and laboratory staff who handle Neisseria meningitidis.

Varicella (chickenpox)

Target: age_from:null · age_to:null · sex:any · conditions:[seronegative_HCW · seronegative_close_contact_of_immunocompromised]

2 doses for non-immune (seronegative) healthcare workers + non-immune close contacts of immunocompromised patients. Live vaccine — contraindicated in pregnancy/immunosuppression.

BCG (tuberculosis)

Target: age_from:null · age_to:null · sex:any · conditions:[unvaccinated_tuberculin_negative_HCW_with_TB_patient_contact · lab_staff_handling_TB · occupational_high_TB_exposure]

UK offers occupational BCG to unvaccinated, tuberculin-negative HCW/lab staff with potential TB exposure (NOT routine in US). Single intradermal dose.

Official source

primary:
UKHSA 'Green Book' — Immunisation against infectious disease (chapters per antigen + Chapter 11 schedule)
advisory body:
JCVI (Joint Committee on Vaccination and Immunisation)
schedule doc:
Complete Routine Immunisation Schedule (GOV.UK, updated periodically)
occupational basis:
COSHH 2002 (biological agents) + Green Book Chapter 12 (immunisation of healthcare and laboratory staff) + employer duty

Reportar a xOH

Si detectas un error clinico, una dosis sospechosa o quieres sugerir una mejora. No incluyas datos identificables del paciente en el cuerpo del email, por favor.

Adjuntamos URL + version automaticamente. Tu email queda gestionado por tu cliente local. xOH no recibe ni almacena nada.